P

Inventor

MICHAELIDES MICHAEL R

US36 patents
⚠️ This page may combine multiple inventors who share the name “MICHAELIDES MICHAEL R”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

ABBOTT LAB

18 patents
US7297709B2Nov 20, 2007

Indazole, benzisoxazole, and benzisothiazole kinase inhibitors

ABBOTT LAB92 citations98
US6294573B1Sep 25, 2001

Reverse hydroxamate inhibitors of matrix metalloproteinases

ABBOTT LAB131 citations97
US6235786B1May 22, 2001

Reverse hydroxamate inhibitors of matrix metalloproteinases

ABBOTT LAB103 citations96
US5952320ASep 14, 1999

Macrocyclic inhibitors of matrix metalloproteinases and TNFα secretion

ABBOTT LAB34 citations92
US5597832AJan 28, 1997

Tetracyclic compounds as dopamine agonists

ABBOTT LAB34 citations92
US5811425ASep 22, 1998

Heterocyclic compounds as COX-2 inhibitors

ABBOTT LAB44 citations90
US4994486AFeb 19, 1991

Dopaminergic compounds

ABBOTT LAB23 citations90
US7829570B2Nov 9, 2010

Substituted 4-amino isoxazolo[5,4-d]pyrimidines as kinase inhibitors

ABBOTT LAB14 citations83
US7812166B2Oct 12, 2010

Kinase inhibitors

ABBOTT LAB15 citations83
US7202363B2Apr 10, 2007

Thienopyridine and furopyridine kinase inhibitors

ABBOTT LAB12 citations82
US7598283B2Oct 6, 2009

Indazole, benzisoxazole, and benzisothiazole kinase inhibitors

ABBOTT LAB5 citations73
US5985911ANov 16, 1999

C-terminal ketone inhibitors of matrix metalloproteinases and TNFα secretion

ABBOTT LAB10 citations72
US6288261B1Sep 11, 2001

Inhibitors of matrix metalloproteinases

ABBOTT LAB10 citations71
US7560552B2Jul 14, 2009

Thiopyrimidine and isothiazolopyrimidine kinase inhibitors

ABBOTT LAB3 citations62
US7737160B2Jun 15, 2010

Thienopyridine and furopyridine kinase inhibitors

ABBOTT LAB2 citations60
US7468371B2Dec 23, 2008

Tricyclic pyrazole kinase inhibitors

ABBOTT LAB4 citations60
US7795248B2Sep 14, 2010

Substituted 7,8-dihydro-1H-pyrimido[4,5-B][1,4]diazepin-4-amines are novel kinase inhibitors

ABBOTT LAB0 citations38
US5659037AAug 19, 1997

Process for preparing chiral tetracyclic dopaminergic compounds

ABBOTT LAB0 citations34

ABBVIE INC

7 patents

MICHAELIDES MICHAEL R

5 patents

DAI YUJIA

3 patents

CURTIN MICHAEL

1 patent

ZHU GUI-DONG

1 patent

BETSCHMANN PATRICK

1 patent